Tecan to expand U.S. pipette tip manufacturing for COVID-19 testing supported through a $32.9 million investment by the U.S. Government

Date Published10/27/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Tecan Group, Ltd.
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
Country(ies) from which reshored:Switzerland
If relevant, work nearshored to:-
Industry(ies):Plastic & Rubber Products, Miscellaneous – subset non Hobbies, biopharmaceuticals
Product(s) reshoredDisposable pipette tips, pipette tips for tests
What domestic positive factors made reshoring more attractive?Government Incentives, Impact on domestic economy, Lead time/Time to market, Skilled workforce availability/training, Other, Covid-19
Government Incentive dollar amount:$32.9 million
Find Reshoring Articles